|
7-[3-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2H-isoquinolin-1-one |
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Jarvis C, et al. 2016. ChemMedChem |
|
Avasimibe |
Depiction based on curated SMILES
O
H
3
C
CH
3
CH
3
CH
3
CH
3
H
3
C
H
3
C
CH
3
CH
3
CH
3
O
S
O
O
HN
|
Escherichia Salmonella |
TTSS secreted effectors TTSS-2 secreted effectors |
Preclinical (in vivo) Preclinical (in vivo) |
Hasan MK, et al. 2022. Pathogens
|
|
Geraniol |
Depiction based on curated SMILES
CH
3
HO
CH
3
CH
3
|
Shigella |
DsbA |
Preclinical (in vivo) |
Mirza ZRMH, et al. 2018. Virulence |
|
Shionone |
Depiction based on curated SMILES
CH
3
CH
3
CH
3
CH
3
CH
3
H
3
C
CH
3
H
O
H
CH
3
H
|
Streptococcus |
Pneumolysin |
Preclinical (in vivo) |
Du R, et al. 2022. Molecules |
|
Linalool |
Depiction based on curated SMILES
CH
3
H
3
C
CH
2
OH
CH
3
|
Streptococcus |
Biofilm |
Preclinical (in vivo) |
Praseetha S, et al. 2023. Antibiotics (Basel) |
|
N-Dodecyl-4-(2-amino-1H-imidazole-4-yl)butanamide |
Depiction based on curated SMILES
N
H
N
H
2
N
N
H
O
CH
3
|
Streptococcus |
Biofilm |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-hexadecylbutanamide |
Depiction based on curated SMILES
N
H
2
N
N
H
O
N
H
CH
3
|
Streptococcus |
Biofilm |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-octadecylbutanamide |
Depiction based on curated SMILES
N
H
2
N
N
H
O
N
H
CH
3
|
Streptococcus |
Biofilm |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-tetradecylbutanamide |
Depiction based on curated SMILES
N
H
2
N
N
H
O
N
H
CH
3
|
Streptococcus |
Biofilm |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-undecylbutanamide |
Depiction based on curated SMILES
N
H
N
NH
2
HN
O
H
3
C
|
Streptococcus |
Biofilm |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
| | |